Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.
The endocrine and therapeutic effects of the aromatase inhibitor fadrozole hydrochloride have been assessed in 80 post-menopausal patients with recurrent breast cancer after tamoxifen failure. Treatment allocation was randomly 0.5, 1.0 or 2.0 mg orally b.d. Eight patients were not assessable for res...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group
1996
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074462/ |